Clinical Endocrinology

The assessment of growth hormone deficiency in children and adults with particular reference to the transitional period
pp. 545-547(3)
Authors: Monson J.P.; Hindmarsh P.

Cabergoline and quinagolide therapy for prolactinomas
pp. 549-550(2)
Author: Webster J.

Elderly people with hypothalamic–pituitary disease and growth hormone deficiency: lipid profiles, body composition and quality of life compared with control subjects
pp. 551-559(9)
Authors: Li Voon Chong J.S.W.; Benbow S.; Foy P.; Wallymahmed M.E.; Wile D.; MacFarlane I.A.

Effects of DHEA replacement on bone mineral density and body composition in elderly women and men
pp. 561-568(8)
Authors: Villareal D.T.; Holloszy J.O.; Kohrt W.M.

Beta cell function declines with age in glucose tolerant Caucasians
pp. 569-575(7)
Authors: Chiu K.C.; Lee N.P.; Cohan P.; Chuang L-M.

Comparison of octreotide acetate LAR and lanreotide SR in patients with acromegaly
pp. 577-586(10)
Authors: Chanson P.; Boerlin V.; Ajzenberg C.; Bachelot Y.; Benito P.; Bringer J.; Caron P.; Charbonnel B.; Cortet C.; Delemer B.; Escobar-Jiménez F.; Foubert L.; Gaztambide S.; Jockenhoevel F.; Kuhn J.M.; Leclere J.; Lorcy Y.; Perlemuter L.; Prestele H.; Roger P.; Rohmer V.; Santen R.; Sassolas G.; Scherbaum W.A.; Schopohl J.; Torres E.; Varela C.; Villamil F.; Webb S.M.

Cholinergic modulation of growth hormone responses to growth hormone-releasing hormone in uraemic patients on peritoneal dialysis
pp. 587-593(7)
Authors: Díez J.J.; Iglesias P.; Selgas R.; Bajo M.A.; Aguilera A.

Recovery of growth hormone secretion following cabergoline treatment of macroprolactinomas
pp. 595-599(5)
Authors: George L.D.; Nicolau N.; Scanlon M.F.; Davies J.S.

Sweat secretion rates in growth hormone disorders
pp. 601-608(8)
Authors: Sneppen S.B.; Main K.M.; Juul A.; Pedersen L.M.; Kristensen L.Ø.; Skakkebæk N.E.; Feldt-Rasmussen U.

The effect of distinct activating mutations of the luteinizing hormone receptor gene on the pituitary–gonadal axis in both sexes
pp. 609-613(5)
Authors: Latronico A.C.; Lins T.S.S.; Brito V.N.; Arnhold I.J.P.; Mendonca B.B.

Salivary, but not serum or urinary levels of progesterone are elevated after topical application of progesterone cream to pre-and postmenopausal women
pp. 615-620(6)
Authors: O'leary P.; Feddema P.; Chan K.; Taranto M.; Smith M.; Evans S.

Parathyroid hormone-related protein in the aetiology of fibrous dysplasia of bone in the McCune Albright syndrome
pp. 621-628(8)
Authors: Fraser W.D.; Walsh C.A.; Birch M.A.; Durham B.; Dillon J.P.; McCreavy D.; Gallagher J.A.

Determinants of thyroid volume as measured by ultrasonography in healthy adults randomly selected
pp. 629-634(6)
Authors: Gómez J.M.; Maravall F.J.; Gómez N.; Gumà A.; Soler J.

Over-expression of hepatocyte growth factor/scatter factor (HGF/SF) and the HGF/SF receptor (cMET) are associated with a high risk of metastasis and recurrence for children and young adults with papillary thyroid carcinoma
pp. 635-644(10)
Authors: Ramirez R.; Hsu D.; Patel A.; Fenton C.; Dinauer C.; Tuttle R.M.; Francis G.L.

Placental growth hormone and IGF-I in a pregnant woman with Pit-1 deficiency
pp. 645-647(3)
Authors: Verhaeghe J.; Bougoussa M.; Van Herck E.; de Zegher F.; Hennen G.; Igout A.

Simultaneous peripubertal onset of multireactive autoimmune diseases with an unusual long-lasting remission of type 1 diabetes mellitus
pp. 649-653(5)
Authors: Valerio G.; Iovino A.F.A.; Tanga M.; Alessio M.; Pignata C.

Influence of thyroid pathology on the results of parathyroid gammagraphy with Tc^99m-sestamibi
pp. 655-656(2)
Authors: Piñero A.; Rodriguez J.M.; Ortiz S.; Claver M.A.; Parrilla P.

Cutaneous pseudolymphoma associated with bromocriptine therapy
pp. 656-657(2)
Authors: Wiesli P.; Joos L.; Galeazzi R.L.; Dummer R.

Insulin Resistance: The Metabolic Syndrome X G.M. Reaven and A. Laws (Eds.) John Wiley & Sons, 1999. pp. 374, $145, ISBN: 0–896–03588–3 (hb)
pp. 659-659(1)
Author: Aitman T.J.

Intramuscular testosterone indecanoate with or without oral levonorgestrel: a randomized placebo feasability study for male contraception
pp. 661-661(1)
Authors: Kamischke A.; Plöger D.; Venherm S.; von Eckardstein S.; von Eckardstein .; Nieschlag E.